Natera
Natera is seeking a senior-level scientist to design and deploy production-grade autonomous AI agents and multi-modal foundation models that translate complex multi-omic data into clinical insights for cancer biomarker and therapeutic discovery. The role leads the technical strategy, architecture, and roadmap for agentic AI workflows across the Biopharma Solutions and Therapeutics Discovery division, ensuring reproducible, transparent, and audit‑ready machine learning systems.
Headquarters
Austin, Texas, United States
Company Size
1001-5000 employees
Founded
2004
Natera is a molecular diagnostics company that develops and commercializes cell-free DNA testing for oncology, women's health, organ health, and rare disease. Its tests are used for cancer detection and monitoring, noninvasive prenatal and carrier screening, transplant rejection assessment, and genomic analysis for rare diseases. Natera's clinically validated tests are processed in CAP/CLIA-certified labs and supported by over 400 peer-reviewed publications.
Headquarters
San Francisco, CA
Company Size
201-500 employees
Founded
2018
Industry
Technology
Glassdoor Rating
4.2 / 5
Sarah Johnson
Chief Executive Officer
Michael Chen
Chief Technology Officer
Emily Williams
VP of Engineering
David Rodriguez
VP of Product
Jessica Thompson
Chief Financial Officer
Andrew Park
VP of Sales
View leadership team, funding history,
and employee contacts for Natera.
Natera's 1.18% Stock Decline Despite $280M Volume Surge Ranks 429th in Trading Activity
14 hours ago
Senior Director of Bioinformatics
Summit Therapeutics,
Director of Oncology Data Scientist
Merck & Co., Inc.
Data Scientist - Agentic AI Systems - Loops
IFS
Data Scientist - Agentic AI Systems - IFS Loops
IFS
Director, Computational Pathology Biomarker Lead (Oncology/BioPharma) (m/f/d)
AstraZeneca
Director of Oncology Data Scientist
Merck & Co., Inc.